Molina Healthcare, Inc $MOH Shares Sold by Cambiar Investors LLC

Key Points

• Cambiar Investors LLC reduced its holdings in Molina Healthcare by 9.6%, selling 3,195 shares and retaining 29,941 shares, valued at approximately $9.86 million.
• Several institutional investors made significant adjustments to their positions in Molina Healthcare, with Rothschild Investment LLC increasing its holdings by 126.3% during the first quarter.
• The company's latest earnings report showed a net revenue increase of 15.7% year-over-year, but earnings per share fell short of analysts' expectations.

Cambiar Investors LLC lessened its stake in Molina Healthcare, Inc (NYSE:MOH - Free Report) by 9.6% during the 1st quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 29,941 shares of the company's stock after selling 3,195 shares during the period. Cambiar Investors LLC owned 0.06% of Molina Healthcare worth $9,862,000 as of its most recent SEC filing.

Other institutional investors have also recently added to or reduced their stakes in the company. Rothschild Investment LLC increased its position in Molina Healthcare by 126.3% in the 1st quarter. Rothschild Investment LLC now owns 86 shares of the company's stock valued at $28,000 after acquiring an additional 48 shares during the period. Zions Bancorporation National Association UT purchased a new stake in Molina Healthcare in the 1st quarter valued at approximately $29,000. Deseret Mutual Benefit Administrators boosted its holdings in Molina Healthcare by 60.7% in the 1st quarter. Deseret Mutual Benefit Administrators now owns 90 shares of the company's stock valued at $30,000 after purchasing an additional 34 shares in the last quarter. Colonial Trust Co SC boosted its holdings in Molina Healthcare by 930.0% in the 4th quarter. Colonial Trust Co SC now owns 103 shares of the company's stock valued at $30,000 after purchasing an additional 93 shares in the last quarter. Finally, Silver Oak Securities Incorporated purchased a new stake in Molina Healthcare in the 1st quarter valued at approximately $34,000. Institutional investors and hedge funds own 98.50% of the company's stock.

Insiders Place Their Bets

In related news, Director Ronna Romney sold 700 shares of the stock in a transaction on Wednesday, August 6th. The stock was sold at an average price of $153.74, for a total value of $107,618.00. Following the completion of the sale, the director directly owned 17,131 shares in the company, valued at approximately $2,633,719.94. This represents a 3.93% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, COO James Woys purchased 10,000 shares of the stock in a transaction that occurred on Monday, August 4th. The stock was bought at an average price of $155.94 per share, with a total value of $1,559,400.00. Following the completion of the acquisition, the chief operating officer owned 74,331 shares in the company, valued at $11,591,176.14. This represents a 15.54% increase in their position. The disclosure for this purchase can be found here. Corporate insiders own 1.10% of the company's stock.

Wall Street Analyst Weigh In

A number of brokerages have weighed in on MOH. Truist Financial reaffirmed a "hold" rating and issued a $180.00 price objective (down previously from $335.00) on shares of Molina Healthcare in a report on Friday, July 25th. UBS Group lowered their price objective on Molina Healthcare from $260.00 to $180.00 and set a "neutral" rating on the stock in a report on Friday, July 25th. Mizuho lowered their price objective on Molina Healthcare from $400.00 to $330.00 and set an "outperform" rating on the stock in a report on Friday, July 11th. Barclays lowered their price objective on Molina Healthcare from $270.00 to $186.00 and set an "equal weight" rating on the stock in a report on Friday, July 25th. Finally, Morgan Stanley lowered Molina Healthcare from an "overweight" rating to an "equal weight" rating and lowered their price objective for the company from $364.00 to $266.00 in a report on Thursday, July 10th. Three research analysts have rated the stock with a Buy rating and ten have issued a Hold rating to the stock. According to data from MarketBeat.com, the company currently has a consensus rating of "Hold" and an average price target of $242.91.

Molina Healthcare Price Performance

MOH stock traded down $0.9520 on Thursday, reaching $172.6480. The company had a trading volume of 1,366,380 shares, compared to its average volume of 992,687. Molina Healthcare, Inc has a 1 year low of $151.95 and a 1 year high of $365.23. The company has a debt-to-equity ratio of 0.77, a quick ratio of 1.66 and a current ratio of 1.66. The company's fifty day moving average is $215.91 and its 200 day moving average is $279.11. The company has a market cap of $9.36 billion, a P/E ratio of 8.51 and a beta of 0.52.

Molina Healthcare (NYSE:MOH - Get Free Report) last posted its earnings results on Wednesday, July 23rd. The company reported $5.48 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $5.50 by ($0.02). Molina Healthcare had a net margin of 2.60% and a return on equity of 27.72%. The company had revenue of $11.43 billion during the quarter, compared to analysts' expectations of $10.94 billion. During the same period in the previous year, the company posted $5.86 EPS. Molina Healthcare's quarterly revenue was up 15.7% compared to the same quarter last year. On average, research analysts forecast that Molina Healthcare, Inc will post 24.4 earnings per share for the current year.

Molina Healthcare Company Profile

Molina Healthcare, Inc provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments: Medicaid, Medicare, Marketplace, and Other. The company served in across 19 states. The company was founded in 1980 and is headquartered in Long Beach, California.